Transactions

Our Capabilities

Financings:

Private Placement (PP)
Private Investment in Public Equity (PIPE)
Registered Direct (RD)
Confidentially Marketed Public Offering (CMPO)
Equity Line of Credit (ELOC)

Licensing:

Inward Corporate Licensing (ICL) of Global and Regional Rights
Outward Corporate Licensing (OCL) of Global and Regional Rights

Mergers & Acquisitions:

Acquisitions
Divestments including Spin-Offs, Split-Offs, Carve-Outs, Asset Sales
Special Purpose Acquisition Corp (SPAC) Mergers
Fairness Opinions

Our Transactions

$27,500,000

Equity & Debt Financing of MolecuLight led by

financings

Up to $72,600,000

Public Equity Financing of Traws Pharma led by

financings

$9,210,000

Public Equity Financing of BioAtla led by

financings

$19,500,000

Public Debt Financing of Virios Therapeutics led by

financings

$100,000,000

Acquisition by Virios Therapeutics of

m&a

Up to $27,000,000

Public Equity Financing of Onconetix led by

financings

Up to $133,500,000

Plus Royalties Outward Global License of BA3362 to

licensing

$11,700,000

Equity Financing of MolecuLight led by

financings

$14,000,000

Public Equity Financing of Onconova Therapeutics led by

financings

$100,000,000

Acquisition by Onconova Therapeutics of

m&a

$5,000,000

Public Equity Financing of Onconetix led by

financings

$95,000,000

Acquisition by First Wave Biopharma of

m&a

$75,000,000

Divestment of Proteomedix to

m&a

Up to $18,000,000

Divestment of DMX-1002 to

m&a

Up to $42,000,000

Outward US License of Proclarix® to

licensing

$23,000,000

Equity Financing of Prognos Health led by

financings

$8,000,000

Equity Financing of MolecuLight led by

financings

$6,700,000

Equity Financing of MFS Corp led by

financings

Up to $113,000,000

Divestment of VCN Biosciences to

m&a

$10,000,000

Debt Financing of Moleculight led by

financings

$2,250,000

Equity Financing of iPill led by

financings

Up to $42,000,000

Divestment of Sandstone Diagnostics to

m&a

$2,000,000

Equity Financing of Breonics led by

financings

$10,000,000

Divestment of INUI Health to

m&a

Up to $41,000,000

Inward Global License of KIN-001 from

licensing

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Transactions

Successful track record of originating and executing transactions